Inpatient treatment of severe nicotine dependence

R. D. Hurt, L. C. Dale, K. P. Offord, B. K. Bruce, F. L. McClain, K. M. Eberman

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The most severely nicotine-dependent patients who have tried traditional treatment programs without success may require maximal intervention to achieve abstinence. In the Clinical Research Center at the Mayo Clinic, we assessed the feasibility of an inpatient treatment program for 24 such subjects, who were hospitalized (in groups of 6) for 2 consecutive weeks. A combination of behavioral, chemical-dependence, and transdermal nicotine- replacement therapy was provided in a smoke-free, protected milieu. Components of the program included group therapy, management of stress, exercise, daily lectures, and supervised activities. The mean age of the 18 women and 6 men was 51.3 years (range, 29 to 69 years). The mean duration of smoking was 33.7 years, and the number of cigarettes smoked per day at the time of admission averaged 33.2. The most frequent tobacco-related medical illnesses were chronic obstructive pulmonary disease, arteriosclerosis obliterans, and coronary artery disease. All subjects but two - each smoked part of a cigarette-remained abstinent from the use of cigarettes while in the Clinical Research Center, and all completed the 2-week inpatient program. The subjects underwent follow-up for 10 weeks after dismissal and were contacted periodically thereafter. At 1 year, 7 of the 24 subjects (29%) had maintained continuous abstinence from smoking, and their self-reported status at 1 year was verified biochemically.

Original languageEnglish (US)
Pages (from-to)823-828
Number of pages6
JournalMayo Clinic Proceedings
Volume67
Issue number9
StatePublished - 1992
Externally publishedYes

Fingerprint

Tobacco Use Disorder
Tobacco Products
Inpatients
Smoking
Arteriosclerosis Obliterans
Group Psychotherapy
Nicotine
Research
Smoke
Chronic Obstructive Pulmonary Disease
Tobacco
Coronary Artery Disease
Therapeutics
Exercise

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hurt, R. D., Dale, L. C., Offord, K. P., Bruce, B. K., McClain, F. L., & Eberman, K. M. (1992). Inpatient treatment of severe nicotine dependence. Mayo Clinic Proceedings, 67(9), 823-828.

Inpatient treatment of severe nicotine dependence. / Hurt, R. D.; Dale, L. C.; Offord, K. P.; Bruce, B. K.; McClain, F. L.; Eberman, K. M.

In: Mayo Clinic Proceedings, Vol. 67, No. 9, 1992, p. 823-828.

Research output: Contribution to journalArticle

Hurt, RD, Dale, LC, Offord, KP, Bruce, BK, McClain, FL & Eberman, KM 1992, 'Inpatient treatment of severe nicotine dependence', Mayo Clinic Proceedings, vol. 67, no. 9, pp. 823-828.
Hurt RD, Dale LC, Offord KP, Bruce BK, McClain FL, Eberman KM. Inpatient treatment of severe nicotine dependence. Mayo Clinic Proceedings. 1992;67(9):823-828.
Hurt, R. D. ; Dale, L. C. ; Offord, K. P. ; Bruce, B. K. ; McClain, F. L. ; Eberman, K. M. / Inpatient treatment of severe nicotine dependence. In: Mayo Clinic Proceedings. 1992 ; Vol. 67, No. 9. pp. 823-828.
@article{6f3d0bca16f349a58f8c8be563d86bf1,
title = "Inpatient treatment of severe nicotine dependence",
abstract = "The most severely nicotine-dependent patients who have tried traditional treatment programs without success may require maximal intervention to achieve abstinence. In the Clinical Research Center at the Mayo Clinic, we assessed the feasibility of an inpatient treatment program for 24 such subjects, who were hospitalized (in groups of 6) for 2 consecutive weeks. A combination of behavioral, chemical-dependence, and transdermal nicotine- replacement therapy was provided in a smoke-free, protected milieu. Components of the program included group therapy, management of stress, exercise, daily lectures, and supervised activities. The mean age of the 18 women and 6 men was 51.3 years (range, 29 to 69 years). The mean duration of smoking was 33.7 years, and the number of cigarettes smoked per day at the time of admission averaged 33.2. The most frequent tobacco-related medical illnesses were chronic obstructive pulmonary disease, arteriosclerosis obliterans, and coronary artery disease. All subjects but two - each smoked part of a cigarette-remained abstinent from the use of cigarettes while in the Clinical Research Center, and all completed the 2-week inpatient program. The subjects underwent follow-up for 10 weeks after dismissal and were contacted periodically thereafter. At 1 year, 7 of the 24 subjects (29{\%}) had maintained continuous abstinence from smoking, and their self-reported status at 1 year was verified biochemically.",
author = "Hurt, {R. D.} and Dale, {L. C.} and Offord, {K. P.} and Bruce, {B. K.} and McClain, {F. L.} and Eberman, {K. M.}",
year = "1992",
language = "English (US)",
volume = "67",
pages = "823--828",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "9",

}

TY - JOUR

T1 - Inpatient treatment of severe nicotine dependence

AU - Hurt, R. D.

AU - Dale, L. C.

AU - Offord, K. P.

AU - Bruce, B. K.

AU - McClain, F. L.

AU - Eberman, K. M.

PY - 1992

Y1 - 1992

N2 - The most severely nicotine-dependent patients who have tried traditional treatment programs without success may require maximal intervention to achieve abstinence. In the Clinical Research Center at the Mayo Clinic, we assessed the feasibility of an inpatient treatment program for 24 such subjects, who were hospitalized (in groups of 6) for 2 consecutive weeks. A combination of behavioral, chemical-dependence, and transdermal nicotine- replacement therapy was provided in a smoke-free, protected milieu. Components of the program included group therapy, management of stress, exercise, daily lectures, and supervised activities. The mean age of the 18 women and 6 men was 51.3 years (range, 29 to 69 years). The mean duration of smoking was 33.7 years, and the number of cigarettes smoked per day at the time of admission averaged 33.2. The most frequent tobacco-related medical illnesses were chronic obstructive pulmonary disease, arteriosclerosis obliterans, and coronary artery disease. All subjects but two - each smoked part of a cigarette-remained abstinent from the use of cigarettes while in the Clinical Research Center, and all completed the 2-week inpatient program. The subjects underwent follow-up for 10 weeks after dismissal and were contacted periodically thereafter. At 1 year, 7 of the 24 subjects (29%) had maintained continuous abstinence from smoking, and their self-reported status at 1 year was verified biochemically.

AB - The most severely nicotine-dependent patients who have tried traditional treatment programs without success may require maximal intervention to achieve abstinence. In the Clinical Research Center at the Mayo Clinic, we assessed the feasibility of an inpatient treatment program for 24 such subjects, who were hospitalized (in groups of 6) for 2 consecutive weeks. A combination of behavioral, chemical-dependence, and transdermal nicotine- replacement therapy was provided in a smoke-free, protected milieu. Components of the program included group therapy, management of stress, exercise, daily lectures, and supervised activities. The mean age of the 18 women and 6 men was 51.3 years (range, 29 to 69 years). The mean duration of smoking was 33.7 years, and the number of cigarettes smoked per day at the time of admission averaged 33.2. The most frequent tobacco-related medical illnesses were chronic obstructive pulmonary disease, arteriosclerosis obliterans, and coronary artery disease. All subjects but two - each smoked part of a cigarette-remained abstinent from the use of cigarettes while in the Clinical Research Center, and all completed the 2-week inpatient program. The subjects underwent follow-up for 10 weeks after dismissal and were contacted periodically thereafter. At 1 year, 7 of the 24 subjects (29%) had maintained continuous abstinence from smoking, and their self-reported status at 1 year was verified biochemically.

UR - http://www.scopus.com/inward/record.url?scp=0026697753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026697753&partnerID=8YFLogxK

M3 - Article

VL - 67

SP - 823

EP - 828

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 9

ER -